Zolpidem Withdrawal Symptoms in Schizophrenia – A Case Report

Authors

  • Anusree Nilavarayath JuniorResident, Department of Psychiatry, Government Medical College, Kannur
  • Navaneeth Ravikumar Junior Resident, Department of Psychiatry, Government Medical College, Kannur
  • Anithakumari Ayirolimeethal Professor, Department of Psychiatry, Government Medical College, Kannur https://orcid.org/0000-0001-5940-1616
  • Padmini Cherukunnath Assistant Professor, Department of Psychiatry, Government Medical College, Kannur https://orcid.org/0009-0001-8525-0900

DOI:

https://doi.org/10.30834/KJP.37.2.2024.468.

Keywords:

Zolpidem Dependence, Zolpidem Withdrawal, Schizophrenia

Abstract

Background: Substance abuse and dependence are common psychiatric co-morbidities in schizophrenia. Many cases of withdrawal symptoms with high doses of zolpidem dependence were reported in mood or anxiety disorders. Here, we present a case of zolpidem withdrawal in a schizophrenia patient.

Case report: A 51-year-old male diagnosed with paranoid schizophrenia presented with restlessness, headache, threatening violence, and craving for zolpidem within about two hours of stopping the drug. Zolpidem was prescribed for insomnia. He developed dependence and experienced withdrawal symptoms even with a one-hour delay in getting zolpidem. It was successfully treated with 1mg of clonazepam.

Discussion: Schizophrenic patients often abuse zolpidem, leading to dependence and withdrawal when prescribed for insomnia. Severe withdrawal symptoms can occur with a lower dose of zolpidem. Zolpidem withdrawal can be treated with benzodiazepines like clonazepam.

Downloads

Download data is not yet available.

References

Dang A, Garg A, Rataboli PV. Role of zolpidem in the management of insomnia. CNS Neurosci Ther. 2011 Oct; 17(5):387-97. DOI: 10.1111/j.1755-5949.2010.00158.x

Orsolini L, Chiappini S, Grandinetti P, Bruschi A, Testa R, Provenzano A et.al. 'Z-trip'? A Comprehensive Overview and a Case-Series of Zolpidem Misuse. Clin Psychopharmacol Neurosci. 2021 May 31; 19(2):367-387. DOI: 10.9758/cpn.2021.19.2.367

Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P. Evidence of zolpidem abuse and dependence: Results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol. 2007 Aug; 64(2):198-209. DOI: 10.1111/j.1365-2125.2007.02861.x

Skowronska K, Chmura A, Pondel K, Cyboran K, Baciur P. Review of the literature on the dangers of zolpidem use, its potential for abuse and addiction. J Educ Health Sport [Internet]. 2022; 12(9):144-9. DOI: 10.12775/JEHS.2022.12.09.018

Nakamura T, Furihata R, Hasegawa N, Kodaka F, Muraoka H et al.: The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study. BMC Psychiatry. 2024 May 29; 24(1):399. DOI: 10.1186/s12888-024-05816-x

Ruhl F, Lambert M, Rohenkohl A, Kraft V, Daubmann A, Schneider BC, et al. Remission with or without comorbid substance use disorders in early psychosis: long-term outcome in integrated care (ACCESS III study). Front. Psychol. 2023; 14:1237718. DOI: 10.3389/fpsyg.2023.1237718

Adlard RJ, Roos T, Temmingh H. Alcohol, Smoking and Substance Involvement Screening Test validity in bipolar and psychotic disorders. S Afr J Psychiatr. 2023 Dec 21; 29:2109. DOI: 10.4102/sajpsychiatry.v29i0.2109

Kar SK, Dwivedi S. Zolpidem dependence in an adult with bipolar affective disorder and epilepsy: A case report. General Psychiatry 2019; 32. PMCID: PMC6738692.

Ward HB, Nemeroff CB, Carpenter L, Grzenda A, McDonald WM, Rodriguez CI, et al. Substance use disorders in schizophrenia: Prevalence, etiology, biomarkers, and treatment. Personalized Medicine in Psychiatry 2023 Jul-Aug; 39–40.Heydari M, Isfeedvajani MS. Zolpidem dependence, abuse and withdrawal: A case report. J Res Med Sci 2013; 18:1006-7. DOI:10.1016/j.pmip.2023.100106

Bajaj V, Kalra I, Bajaj A, Sharma D, Kumar R. A case of zolpidem dependence with extremely high daily doses. Asia Pac Psychiatry. 2019 Dec; 11(4): e12356. DOI: 10.1111/appy.12356

Holm KJ, Goa KL. Zolpidem: an update of its pharmacology, therapeutic efficacy, and tolerability in the treatment of insomnia. Drugs. 2000 Apr; 59(4):865-89. DOI: 10.2165/00003495-200059040-00014

Fernandes WH, Pereira Yda S, O' Tereza S. A case of Zolpidem dependence successfully detoxified with gabapentin. Indian J Psychiatry. 2013 Jul; 55(3):290-2. DOI: 10.4103/0019-5545.117152

Downloads

Published

15-11-2024

How to Cite

Nilavarayath, A., N. Ravikumar, A. Ayirolimeethal, and P. Cherukunnath. “Zolpidem Withdrawal Symptoms in Schizophrenia – A Case Report”. Kerala Journal of Psychiatry, Nov. 2024, doi:10.30834/KJP.37.2.2024.468.

Issue

Section

Case Report